Celldex Therapeutics
CLDX
#4691
Rank
โ‚ฌ1.68 B
Marketcap
25,40ย โ‚ฌ
Share price
6.44%
Change (1 day)
0.46%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ2.24 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is โ‚ฌ2.24 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ3.66 M59.35%
2023-12-31โ‚ฌ2.29 M-38.84%
2022-12-31โ‚ฌ3.75 M39.97%
2021-12-31โ‚ฌ2.68 M-5.09%
2020-12-31โ‚ฌ2.83 M-13.31%
2019-12-31โ‚ฌ3.26 M
2018-12-31N/A-100%
2017-12-31โ‚ฌ5.47 M
2015-12-31โ‚ฌ4.04 M89.59%
2014-12-31โ‚ฌ2.13 M
2013-12-31N/A-100%
2012-12-31โ‚ฌ8.57 M-26.5%
2011-12-31โ‚ฌ11.66 M43.38%
2010-12-31โ‚ฌ8.13 M-15.81%
2009-12-31โ‚ฌ9.66 M6094.81%
2008-12-31โ‚ฌ0.15 M-95.59%
2007-12-31โ‚ฌ3.53 M0.6%
2006-12-31โ‚ฌ3.51 M99.67%
2005-12-31โ‚ฌ1.76 M1181.67%
2004-12-31โ‚ฌ0.13 M
2000-12-31โ‚ฌ0.29 M-47.91%
1999-12-31โ‚ฌ0.55 M-58.51%
1998-12-31โ‚ฌ1.34 M0%
1997-12-31โ‚ฌ1.34 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
โ‚ฌ97.37 M 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ39.27 M 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.56 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ46.83 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ52.20 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ20.47 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA